| Literature DB >> 22046209 |
Christopher M Coleman1, Karen Plant, Susan Newton, Lynsey Hobson, Moira K B Whyte, Mark L Everard.
Abstract
Respiratory Syncytial Virus (RSV) causes annual epidemics of respiratory disease particularly affecting infants. The associated airway inflammation is characterized by an intense neutrophilia. This neutrophilic inflammation appears to be responsible for much of the pathology and symptoms. Previous work from our group had shown that there are factors within the airways of infants with RSV bronchiolitis that inhibit neutrophil apoptosis. This study was undertaken to determine if RSV can directly affect neutrophil survival.NEUTROPHILS WERE ISOLATED FROM CITRATED VENOUS BLOOD (COLLECTED FROM HEALTHY ADULT VOLUNTEERS) BY DISCONTINUOUS PLASMA: Percoll gradient centrifugation and, in some experiments, further purified by negative immunomagnetic bead selection. The effect of RSV on neutrophil survival was measured by Annexin V-PE /To-Pro-3 staining and by morphological changes, using Dif-Quick staining of cytospins.Inhibition of neutrophil apoptosis was observed in neutrophils isolated by standard plasma:Percoll gradient when exposed to RSV but not in ultra pure neutrophil preparations. Adding monocytes back to ultra purified preparations restored the effect. The inhibition of apoptosis was observed with both active and UV inactivated virus. The effect is dependent on a soluble factor and appears to be dependent on CD14 receptors on the monocytes.Entities:
Keywords: Respiratory syncytial virus; apoptosis; monocytes.; neutrophils
Year: 2011 PMID: 22046209 PMCID: PMC3204419 DOI: 10.2174/1874357901105010114
Source DB: PubMed Journal: Open Virol J ISSN: 1874-3579
Representative Data of the Effect of Depletion of CD3 Positive, CD19 Positive and CD56 Positive Cells from Plasma: Percoll Purified Neutrophil Populations. Cells were Infected with RSV at an m.o.i. of 2 and Apoptosis was Assessed at 12 Hours Post-Infection. Experiments were Performed at Least Twice on Cells from Different Donors
| Depletion Performed. | Donor Matched Plasma: Percoll Purified Neutrophils (% of Apoptotic Cells) | Donor Matched Ultra Purified Neutrophils (% of Apoptotic Cells) | Depleted Cell Population (% of Apoptotic Cells) |
|---|---|---|---|
| CD3 | 6.34% | 30.90% | 9.2% |
| CD19 | 16.37% | 31.58% | 18.06% |
| CD56 | 15.33% | 26.67% | 6.00% |
Cytokine and Chemokine Levels, Measured in pg/ml, in Plasma: Percoll Purified Cell Population in Presence or Absence of A2-RSV
| Mock | A2-RSV (m.o.i. 2) | A2-RSV (m.o.i. 10) | |
|---|---|---|---|
| IFN-γ | 14.16 | BDL | BDL |
| TNF-α | 2.83 | 66.55±19.86 | 304.63±106.92 |
| IL-1β | 5.04 | 60.85±19.62 | 113.57±23.56 |
| IL-6 | BDL | 370.78±211.30 | 1456.74±714.64 |
| IL-9 | 27.09 | 13.66±13.66 | 17.18±10.55 |
| IL-10 | 2.71 | 6.76±2.96 | 15.02±4.84 |
| IL-12p70 | BDL | 5.01±5.01 | BDL |
| G-CSF | BDL | 18.76±6.39 | 53.38±22.71 |
| GM-CSF | 4.03 | 3.44±3.44 | 2.61±2.61 |
| MIP-1α | 2.69 | 765.37±199.18 | 3823.72±855.41 |
| MIP-1β | 70.00 | ADL | ADL |
Data is mean values +/- standard error of 4 independent experiments. Mock infected controls are mean values of 2 independent experiments. BDL = below detection limit; ADL = above detection limit.
Cytokine and Chemokine Levels, Measured in pg/ml, in the Ultra Purified Cell Population in Presence or Absence of A2-RSV
| Mock | A2-RSV (m.o.i. 2) | A2-RSV (m.o.i. 10) | |
|---|---|---|---|
| IFN-γ | BDL | BDL | BDL |
| TNF-α | BDL | 2.46±1.50 | 1.53±1.53 |
| IL-1β | BDL | 2.73±1.63 | 2.33±2.33 |
| IL-6 | BDL | 7.91±2.29 | 16.40±5.05 |
| IL-9 | 24.43 | 7.15±7.15 | 3.99±3.99 |
| IL-10 | BDL | 2.65±1.53 | BDL |
| IL-12p70 | BDL | BDL | 2.78±2.78 |
| G-CSF | BDL | BDL | 4.71±4.71 |
| GM-CSF | BDL | BDL | 2.67±2.67 |
| MIP-1α | BDL | 25.21±4.47 | 114.69±46.45 |
| MIP-1β | BDL | 816.00±147.60 | 3307.50±865.19 |
Data is shown as mean values +/- standard error of 4 independent experiments. Mock infected controls are mean values of 2 independent experiments. BDL = below detection limit.